A carregar...
Prostate cancer screening—when to start and how to screen?
Prostate-specific antigen (PSA) screening reduces prostate cancer (PCa) mortality; however such screening may lead to harm in terms of overdiagnosis and overtreatment. Therefore, upfront shared decision making involving a discussion about pros and cons between a physician and a patient is crucial. T...
Na minha lista:
| Publicado no: | Transl Androl Urol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861291/ https://ncbi.nlm.nih.gov/pubmed/29594018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.12.25 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|